Why the study?
Does the (+/+) lipoprotein lipase-HindIII genotype associate with the clustering of insulin-resistance syndrome components in normoglycemic individuals?
Does the (+/+) lipoprotein lipase-HindIII genotype associate with the clustering of insulin-resistance syndrome components in normoglycemic individuals?
The (+/+) lipoprotein lipase-HindIII genotype is significantly associated with the clustering of insulin-resistance syndrome components, representing a potential genetic basis for metabolic risk.
Answers are grounded in this paper and cite their sources.
Should not yet guide genotyping in normoglycemic patients; leaves open causal role of LPL-HindIII in insulin-resistance clustering.
OBJECTIVE: To cross-sectionally evaluate the presence of clustering of the insulin-resistance syndrome components. Tests were conducted for association of the HindIII restriction site polymorphism at the lipoprotein lipase locus with clustering of the physiological components of the insulin resistance syndrome. RESEARCH DESIGN AND METHODS: DNA samples of 370 normoglycemic Hispanics and 520 normoglycemic non-Hispanic whites from the San Luis Valley, Colorado, were amplified by the polymerase chain reaction. Lipids and glucose were determined by the standard procedures. Cross-tabulation and chi 2 analysis were used. RESULTS: The insulin-resistance syndrome components (elevated fasting insulin, reduced high-density lipoprotein cholesterol, and elevated triglycerides) appeared together in individuals of this population sample more often than expected by chance. Individuals in the population with the (+/+) lipoprotein lipase-HindIII restriction of fragment-length polymorphism genotype were more likely to have elevated fasting insulin and triglycerides and a reduced high-density lipoprotein-cholesterol level than subjects with the (+/-) genotype (odds ratio = 2.3, 95% confidence interval 1.38-3.98). CONCLUSIONS: As expected from the physiological function of lipoprotein lipase, the primary association of lipoprotein lipase genotypes is with triglyceride and high-density lipoprotein-cholesterol levels. This appears to be the first reported genetic association with the insulin-resistance syndrome and may reflect genotype specific differences in the regulation of lipoprotein lipase by insulin.
No takes yet. Share an insight, caveat, or question.
Ahn et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: